Unlock instant, AI-driven research and patent intelligence for your innovation.

A porcine acute diarrhea syndrome coronavirus artificial chromosome recombinant vector and its construction method and application

An artificial chromosome, acute diarrhea technology, applied in the direction of viruses/phages, viruses, vectors, etc., can solve the problems of poor stability, cumbersome and time-consuming, and achieve the effect of reducing the cost of sequencing, improving the efficiency of recombination and the success rate of screening

Active Publication Date: 2022-08-02
广州安合动保生物科技有限公司
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This new method of constructing and manipulating infectious clones of SADS-CoV has potential reference significance for constructing infectious clones of other RNA viruses with larger genomes, and also provides support for the rapid development of subsequent recombinant vector vaccines, and also overcomes the The disadvantages of cumbersome time-consuming and poor stability in the construction of infectious clones of large-fragment RNA virus genomes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A porcine acute diarrhea syndrome coronavirus artificial chromosome recombinant vector and its construction method and application
  • A porcine acute diarrhea syndrome coronavirus artificial chromosome recombinant vector and its construction method and application
  • A porcine acute diarrhea syndrome coronavirus artificial chromosome recombinant vector and its construction method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0080] Example 1 Construction of SADS-CoV full-length infectious clone

[0081] Primer design principles: when designing primers, preset NotI and ApaI restriction sites at both ends of the vector pBeloBAC11-cm, preset NotI and XbaI restriction sites at both ends of the vector pBeloBAC11-spect (F1-F6), and preset NotI and XbaI restriction sites at both ends of the vector pBeloBAC11-spect EcoRV restriction sites are preset at both ends of pBeloBAC11-spect (F7-F10), and EcoRV restriction sites are preset at both ends of vector p15A-amp (F11-F14). Homologous arms are designed between each amplification primer sequence. There is an overlap of 30~60bp between the primers, which is synthesized by Sangon Bioengineering (Shanghai) Co., Ltd. The specific sequences of the primers are shown in SEQ ID NO.1~42. .

[0082] PCR amplification program: 94 ℃ for 5 min; 98 ℃ for 10 s, 45-60 ℃ for 5 s, 72 ℃ for 5-90 s (according to the size of the target fragment, extension speed 10 s / kb), set 32...

Embodiment 2

[0112] Example 2 Construction of helper plasmid expressing SADS-CoV structural protein N

[0113] When designing primers, design homology arms between each amplification primer sequence. There is a 30-60 bp overlap between the primers. The specific sequences of the primers are shown in SEQ ID NO. Co., Ltd. synthesis.

[0114] PCR amplification procedure: same as Example 1.

[0115] PCR amplification reaction system: PrimeSTAR Max DNA Polymearse 25 μL, upstream and downstream primers (10pmol / μL) 0.5 μL each, template 0.5 μL, add ddH 2 O make up to 50 μL.

[0116] Gel recovery of amplification products: Place each PCR product on a 1% agarose gel for electrophoresis, and set the voltage and time on the electrophoresis apparatus to 125 V for 30 min respectively. After electrophoresis, under the ultraviolet light of the gel imager, carefully cut the gel at the target fragment band and place it in a sterilized 2 mL EP tube. Follow the gel recovery kit (TIANGEN). , DP214-03) inst...

Embodiment 3

[0125] Example 3 Construction of Recombinant Plasmids Deleting Part or All of ORF3a or ORF7a or ORF7b

[0126] Primer design principle: When designing primers, preset AscI restriction sites at both ends of amp-ccdB. Homologous arms are designed between each amplification primer sequence, and there is an overlap of 30~60bp between the primers. The specific sequences of the primers are shown in SEQ ID NO.108~121, and they are synthesized by Sangon Bioengineering (Shanghai) Co., Ltd. .

[0127] PCR amplification procedure: same as Example 1.

[0128] PCR amplification reaction system: PrimeSTAR Max DNA Polymearse 25 μL, upstream and downstream primers (10pmol / μL) 0.5 μL each, template 0.5 μL, add ddH 2 O make up to 50 μL.

[0129] Gel recovery of amplification products: Place each PCR product on a 1% agarose gel for electrophoresis, and set the voltage and time on the electrophoresis apparatus to 125 V for 30 min respectively. After electrophoresis, under the ultraviolet ligh...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a porcine acute diarrhea syndrome coronavirus artificial chromosome recombinant vector and its construction method and application. The present invention utilizes Gibson assembly to clone the porcine acute diarrhea syndrome coronavirus genome segment into the bacterial artificial chromosome of Escherichia coli, and co-transfects the full-length infectious clone and auxiliary plasmid into mammalian cells to quickly rescue the gene with the wild-type parental gene. the same virus. The invention bypasses the cumbersome restriction enzyme cutting site design and restriction enzyme connection operation of the traditional method, and the viral BAC is stable in Escherichia coli, and further gene manipulation can be carried out through DNA homologous recombination engineering and reverse screening system. At the same time, the present invention has successfully constructed an infectious clone of the virus strain SADS‑CoV‑WT and established a system based on DNA homologous recombination engineering and ccdB reverse screening system to knock out or insert foreign sources at the positions of accessory protein genes ORF3a and ORF7a / b genetic approach.

Description

technical field [0001] The invention belongs to the technical field of gene recombination and vaccines, and in particular relates to a method for rapidly preparing an infectious BAC clone by cloning porcine acute diarrhea syndrome coronavirus SADS-CoV-WT genome and an infectious clone pBeloBAC11-cm-CI-SADS-CoV-WT- Application of HDVrz-SV40polyA in the construction of recombinant porcine acute diarrhea syndrome coronavirus. Background technique [0002] SADS-CoV is a single-stranded positive-stranded RNA virus with an envelope, which belongs to the genus Coronaviridae in the systematic taxonomy. The SADS-CoV genome is about 27kb in size, including 5'-UTR, 3'-UTR and 9 coding frames. The accessory protein gene of SADS-CoV is a non-essential gene for virus proliferation and assembly. The application of live viral vectors can also knock out the corresponding genes to study their functions. However, the production of recombinant viruses for biological research and vaccine devel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/85C12N15/65C12N15/64C12N1/21C12N7/01C12Q1/02A61K39/215A61P31/14C12R1/93C12R1/19
CPCC12N15/85C12N15/65C12N7/00C12Q1/025A61K39/12A61P31/14C12N2800/204C12N2800/107C12N2770/20021C12N2770/20052C12N2770/20034A61K2039/552G01N2333/245
Inventor 马静云燕晓玲符军
Owner 广州安合动保生物科技有限公司